Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications
Cystic fibrosis (CF) is a complex, potentially life-threatening disease that is most effectively treated through the administration of antibiotics (e.g., colistimethate sodium). Chronic infection with <i>Pseudomonas aeruginosa</i> is one of the most significant events in the pathogenesis...
Main Authors: | Marcus Hill, Matthew Twigg, Emer A. Sheridan, John G. Hardy, J. Stuart Elborn, Clifford C. Taggart, Christopher J. Scott, Marie E. Migaud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/8/379 |
Similar Items
-
Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives
by: Iyyakkannu Sivanesan, et al.
Published: (2022-05-01) -
Formulation of Antimicrobial Tobramycin Loaded PLGA Nanoparticles via Complexation with AOT
by: Marcus Hill, et al.
Published: (2019-06-01) -
Alginates Combined with Natural Polymers as Valuable Drug Delivery Platforms
by: Katarzyna Kruk, et al.
Published: (2022-12-01) -
Applications of Chitosan-Alginate-Based Nanoparticles—An Up-to-Date Review
by: Adelina-Gabriela Niculescu, et al.
Published: (2022-01-01) -
Microencapsulation of Erlotinib and Nanomagnetite Supported in Chitosan as Potential Oncologic Carrier
by: Galo Cárdenas-Triviño, et al.
Published: (2021-04-01)